Relay Therapeutics, Inc. (RLAY) Profit Margins
Over the twelve months to 2026-06-30, Relay Therapeutics, Inc. (RLAY) had operating margin -2999.4%, net margin -2763.6%, free cash flow margin -2050.3%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RLAYRelay Therapeutics, Inc.Follow RLAY — free
—
Price chart with a free account
- Market cap
- 4.0B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Operating margin | -67.5% | -12040.2% | -21670.9% | -1460.1% | -3722.1% | -1971.6% | -2999.4% | |
| Net margin | -63.4% | -12012.9% | -21036.1% | -1338.7% | -3374.7% | -1800.6% | -2763.6% | |
| FCF margin | -126.3% | -2571.0% | -17273.9% | -1191.7% | -2509.5% | -1536.1% | -2050.3% |
USD billions · SEC XBRL
Relay Therapeutics, Inc. — questions
- What is Relay Therapeutics, Inc.'s operating margin?
- -2999.4% over the twelve months to 2026-06-30.
- What is Relay Therapeutics, Inc.'s net profit margin?
- -2763.6% over the twelve months to 2026-06-30.
Every figure on this page comes from Relay Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.